EFNB2

Across TCGA pan-cancer cohorts, EFNB2 mass-spec protein differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of EFNB2’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where EFNB2 mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types EFNB2 is over-expressed in tumor, although a few such as COAD and LUAD show the opposite, repressed pattern.

COAD, PDAC, and LUAD are the cancer types where EFNB2 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in EFNB2 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Female	III,IV	−0.575	<.001	11	view →
PDAC	Female	All	+1.213	<.001	10	view →
LUAD	Female	II,III,IV	−1.112	<.001	9	view →
LSCC	Female	All	−0.950	<.001	8	view →
HNSC	Female	IV	+1.305	.014	3	view →
CCRCC	Male	All	+0.243	.002	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

EFNB2–COAD

Open the COAD breakdown →